ASHNYSEWholesale-Chemicals & Allied ProductsFiscal year ends September 30
ASHLAND INC.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$71.19+0.04 (+0.06%)
Close on Oct 19, 2026
- Market cap
- $3.27K
- P/E (TTM)
- –
- Dividend yield
- 2.30%
ASHLAND INC. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Life Sciences [Member] | $641.00M | $810.00M | $869.00M | $815.00M | $737.00M | $708.00M | $732.00M | $731.00M | – | – | 35.1% | -20.9% |
| Personal Care [Member] | $577.00M | $634.00M | $598.00M | $678.00M | $592.00M | $615.00M | $651.00M | $702.00M | – | – | 31.6% | -9.0% |
| Personal Care [Member] | $577.00M | $634.00M | $598.00M | $678.00M | $592.00M | $615.00M | – | – | – | – | 31.6% | -9.0% |
| Specialty Additives [Member] | $511.00M | $572.00M | $600.00M | $719.00M | $655.00M | $589.00M | $654.00M | $686.00M | – | – | 28.0% | -10.7% |
| Intermediates [Member] | $137.00M | $144.00M | $185.00M | $256.00M | $178.00M | $129.00M | $160.00M | $155.00M | $93.00M | $261.00M | 7.5% | -4.9% |
| Intermediates [Member] | $137.00M | $144.00M | $185.00M | $256.00M | $178.00M | $129.00M | – | – | – | – | 7.5% | -4.9% |
| Performance Materials [Member] | – | – | – | – | – | – | – | – | – | $930.00M | – | – |
| Specialty Ingredients [Member] | – | – | – | – | – | – | $2.38B | $2.47B | $2.22B | $2.09B | – | – |
| Valvoline [Member] | – | – | – | – | – | – | – | – | – | $1.93B | – | – |
| Composites [Member] | – | – | – | – | – | – | – | $942.00M | $779.00M | $669.00M | – | – |
| Intermediates and Solvents [Member] | – | – | – | – | – | – | – | – | $265.00M | $261.00M | – | – |
| Consumer Specialties [Member] | – | – | – | – | – | $1.32B | $1.38B | $1.43B | – | – | – | – |
| Performance Adhesives [Member] | – | – | – | – | – | $310.00M | $345.00M | $351.00M | – | – | – | – |
| Industrial Specialties [Member] | – | – | – | – | – | $899.00M | $999.00M | $1.04B | – | – | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Personal Care [Member] | $90.00M | $73.00M | $52.00M | $102.00M | $73.00M | -$296.00M | $85.00M | $105.00M | – | – | +23.3% |
| Intermediates [Member] | $8.00M | $29.00M | $50.00M | $87.00M | $35.00M | -$10.00M | $28.00M | $25.00M | -$6.00M | -$181.00M | -72.4% |
| Life Sciences [Member] | -$262.00M | $168.00M | $172.00M | $155.00M | $130.00M | $123.00M | $114.00M | $117.00M | – | – | -256.0% |
| Unallocated and Other [Member] | -$273.00M | -$264.00M | -$112.00M | -$114.00M | -$107.00M | -$146.00M | -$159.00M | -$261.00M | -$178.00M | -$169.00M | +3.4% |
| Specialty Additives [Member] | -$338.00M | -$32.00M | $10.00M | $103.00M | $61.00M | -$132.00M | $18.00M | $64.00M | – | – | +956.3% |
| Performance Materials [Member] | – | – | – | – | – | – | – | – | – | -$118.00M | – |
| Specialty Ingredients [Member] | – | – | – | – | – | – | $272.00M | $314.00M | $233.00M | $237.00M | – |
| Valvoline [Member] | – | – | – | – | – | – | – | – | – | $403.00M | – |
| Composites [Member] | – | – | – | – | – | – | – | $73.00M | $67.00M | $63.00M | – |
| Intermediates and Solvents [Member] | – | – | – | – | – | – | – | – | -$12.00M | -$181.00M | – |
| Consumer Specialties [Member] | – | – | – | – | – | -$173.00M | $199.00M | $222.00M | – | – | – |
| Performance Adhesives [Member] | – | – | – | – | – | $56.00M | $58.00M | $52.00M | – | – | – |
| Industrial Specialties [Member] | – | – | – | – | – | -$76.00M | $76.00M | $116.00M | – | – | – |
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| International [Member] | $1.36B | $1.49B | $1.56B | $1.66B | $1.47B | $1.39B | $1.47B | $1.59B | $1.43B | $1.85B | 74.6% | -8.7% |
| United States | $464.00M | $624.00M | $634.00M | $731.00M | $637.00M | $623.00M | $674.00M | $997.00M | $880.00M | $1.17B | 25.4% | -25.6% |
From the segment and revenue-disaggregation notes of Ashland's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.